Japanese flu vaccine makers jack up price ahead of flu season; Supreme Court won't hear challenge to NY public schools vaccination requirement;

> Four Japanese flu vaccine makers have hiked their prices by 50% just ahead of the flu season. Story

> The Supreme Court will not hear a challenge to New York state's requirement that children get vaccinated before starting public school. Article

> Abivax is evaluating HeberNavasc, the new Cuban vaccine for the treatment of chronic hepatitis B in 8 countries. More

Suggested Articles

Amid the COVID-19 pandemic, many teams of researchers are working on potential vaccines. We asked experts to assess progress—and point out challenges.

Fujifilm says it is prepared to ramp up production of Avigan for any country that wants to try it as a potential treatment for COVID-19.

Pfizer posted positive top-line results for a trial of its 20-valent pneumococcal vaccine, potentially setting up a filing by the end of 2020.